Australia's most trusted source of pharma news
Tuesday, 28 January 2020
Lost Your Access?
Aust CAR-T patients must wait
Six months before local manufacturing ready.
Fast review for ulcer bug drug
Mylan antibiotic for Buruli ulcer gets priority.
Kymriah deal done says Hunt
Up to 250 patients to be treated in Australia each year.
Pfizer adds new GP team
Hunting primary reps for 'emerging product'.
Top Aussie targets diabetes
Eye surgeon has type 2 blindness in his sights.
Police access PBS records
Thousands handed over annually with no warrant required.
BMS names new med boss
ANZ med director to oversee expanding team.
Pharma ranked for diversity
Janssen, Vertex, Lilly and CSL among top companies.
Biogen names new ANZ boss
Kylie Bromley replaces Chris Stemple as MD.
Murphy appointed Health Sec
Beauchamp steps down and CMO steps up.
Hottest pharma jobs of 2020
Which job areas are most in demand this year?
Kymriah delay raises questions
Patients frustrated by cancelled announcement.
GSK leads world in resistance
Top big pharma in fight against global health threat.
PBS enough for cannabis
Docs, Guild reject calls for separate subsidy scheme.
Patient group funding targeted
Academics on the warpath again.
CSL wins NBA expansion
New form of blood product Berinert listed from March.
Three new drugs registered
Next Novartis, AbbVie, Celgene therapies arrive.
Ship doctor just made captain
What will DoH be like under Brendan Murphy?
Top of the Hill
Health's looming virus crisis
Is China's coronavirus a viral bushfire?
© 2003 - 2020 Lush Media
Pharma in Focus
Jolly Good Design